Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Hoffmann-La Roche
City of Hope Medical Center
M.D. Anderson Cancer Center
Mayo Clinic
City of Hope Medical Center
New York Medical College
Pfizer
City of Hope Medical Center
City of Hope Medical Center
Washington University School of Medicine
Northwestern University
Tessa Therapeutics